"10.1371_journal.pone.0128794","plos one","2015-06-08T00:00:00Z","Martina Morokutti-Kurz; Marielle König-Schuster; Christiane Koller; Christine Graf; Philipp Graf; Norman Kirchoff; Benjamin Reutterer; Jan-Marcus Seifert; Hermann Unger; Andreas Grassauer; Eva Prieschl-Grassauer; Sabine Nakowitsch","Marinomed Biotechnologie GmbH, Vienna, Austria; Laboratory of Tropical Veterinary Medicine, Veterinary University Vienna, Vienna, Austria","Conceived and designed the experiments: MM MK JS AG EP SN. Performed the experiments: MK CK CG PG NK BR JS. Analyzed the data: MM MK CK JS HU AG EP SN. Wrote the paper: MM CK JS AG EP SN.","The authors have read the journals policy and declare that authors Martina Morokutti-Kurz, Marielle König-Schuster, Christiane Koller, Christine Graf, Philipp Graf, Norman Kirchoff, Benjamin Reutterer, Jan-Marcus Seifert, Andreas Grassauer, Eva Prieschl-Grassauer and Sabine Nakowitsch are employed by Marinomed Biotechnologie GmbH. Authors Hermann Unger, Andreas Grassauer and Eva Prieschl-Grassauer are co-founders of Marinomed Biotechnologie GmbH. Andreas Grassauer and Eva Prieschl-Grassauer are inventors of the patent #WO2009027057; Antiviral composition comprising a sulfated polysaccharide. Marielle König-Schuster, Christiane Koller, Andreas Grassauer and Eva Prieschl-Grassauer are inventors of the patent #WO2011076367 Synergistic antiviral composition and use thereof. Both patents are held by Marinomed Biotechnologie GmbH and are related to the content of the manuscript. A product containing a combination of carrageenan and Zanamivir (related to the content of the manuscript) is under development at Marinomed Biotechnologie GmbH. There are no marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2015","06","Martina Morokutti-Kurz","MMK",12,TRUE,6,7,8,6,TRUE,TRUE,FALSE,0,NA,FALSE
